BIOMAT Database Logo BIOMAT Database Logo

[Proceedings: Changes in endogenous insulin secretion caused by insulin therapy: observation on monocomponent (MC) insulin therapy]. 1974

Y Fukumoto, and K Ichihara, and S Tarui

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Y Fukumoto, and K Ichihara, and S Tarui
[Insulin-induced lipoatrophy--caused by monocomponent insulin?].
December 1989, Orvosi hetilap,
Y Fukumoto, and K Ichihara, and S Tarui
[Changes of insulin antibodies after monocomponent insulin therapy].
October 1982, Horumon to rinsho. Clinical endocrinology,
Y Fukumoto, and K Ichihara, and S Tarui
[Monocomponent insulin therapy].
October 1980, Orvosi hetilap,
Y Fukumoto, and K Ichihara, and S Tarui
[Changes of insulin antibody binding ability during monocomponent insulin therapy].
January 1977, Horumon to rinsho. Clinical endocrinology,
Y Fukumoto, and K Ichihara, and S Tarui
[Experiences with monocomponent (MC) insulin in the treatment of juvenile diabetes].
November 1976, Lakartidningen,
Y Fukumoto, and K Ichihara, and S Tarui
[Proceedings: Effects of endogenous insulin and aminophylline on gastrin secretion].
February 1974, Nihon Naibunpi Gakkai zasshi,
Y Fukumoto, and K Ichihara, and S Tarui
[Our experience with monocomponent insulin therapy].
May 1977, Orvosi hetilap,
Y Fukumoto, and K Ichihara, and S Tarui
[Long-term clinical results with monocomponent insulin (MC lente) in infantile and juvenile diabetes].
January 1976, Annali dell'Ospedale Maria Vittoria di Torino,
Y Fukumoto, and K Ichihara, and S Tarui
Suppression of endogenous insulin secretion after acute hypoglycaemia in man [proceedings].
May 1979, The Journal of endocrinology,
Y Fukumoto, and K Ichihara, and S Tarui
Reversal of insulin lipoatrophy by monocomponent insulin.
December 1978, Singapore medical journal,
Copied contents to your clipboard!